Ozempic for weight loss: what the TikTok hype gets wrong

What did @getslim.ng actually say?

The video shows a healthcare worker administering what they call a "Zempic" (semaglutide) injection to a patient named Mrs. O. The creator walks through the injection process step by step: capping the pen, attaching the needle, setting the dose at 0.5, swabbing the abdomen, injecting, holding for six seconds, and recapping. At the very end, almost as an afterthought, comes one sentence: "Don't start with them people don't see me doctor."

That last line is doing a lot of work. The bulk of the video is an enthusiastic, public-facing tutorial on how to self-administer a GLP-1 receptor agonist. The disclaimer is easy to miss and even harder to parse. That imbalance matters.

Does the science back this up?

The injection technique shown is broadly consistent with manufacturer guidance, so the procedural steps are not wrong. But the science on semaglutide is more complicated than a TikTok injection demo suggests.

Semaglutide 0.5 mg is the standard first escalation dose for Ozempic. The prescribing information published by Novo Nordisk specifies a 4-week titration schedule starting at 0.25 mg before moving to 0.5 mg, specifically to reduce gastrointestinal side effects. Whether Mrs. O is on her first injection at 0.5 mg or has already completed the 0.25 mg phase is unclear from the video.

A 2022 trial by Wilding et al. in the New England Journal of Medicine confirmed semaglutide's efficacy for weight loss at higher doses (2.4 mg weekly), but also documented that adverse events, including nausea, vomiting, and pancreatitis, are dose-dependent and require medical supervision. Subcutaneous injection into the abdomen is a correct site, as confirmed by the STEP trial protocols (Wadden et al., 2021, JAMA).

What did they get wrong (or right)?

Credit where it is due: the physical injection steps shown are largely accurate. Swabbing the site, removing the outer cap, pressing and holding for six seconds, and not recapping the needle tip before disposal are all consistent with standard technique.

What they got wrong, or at minimum dangerously incomplete, is the context. This video has 328,900 views. The overwhelming message is excitement and accessibility: "Send us a DM to begin your journey too." The single vague disclaimer at the end does not offset a video that functions as a promotional injection tutorial.

Semaglutide is a prescription-only medication in most jurisdictions, including Nigeria where this account appears to operate. Showing a dose-setting process without clearly stating that dose selection requires a licensed prescriber is misleading by omission. There is no mention of contraindications, including a personal or family history of medullary thyroid carcinoma or MEN2, which carry an FDA black box warning on semaglutide products. The hashtags mixing Ozempic with gastric sleeve and gastric balloon also conflate pharmacological and surgical interventions with no clinical context.

What should you actually know?

Semaglutide injections are not a casual wellness product. They are a regulated pharmaceutical requiring a prescription, proper screening, and ongoing clinical monitoring. The six-second hold the creator mentions is correct. The dose of 0.5 mg shown is a real clinical dose. But watching a TikTok and DMing a clinic is not a substitute for a medical consultation, regardless of how approachable the video makes it look.

If you are considering a GLP-1 medication for weight management, here is what actually needs to happen first:

• A prescriber must review your full medical history, including thyroid history and any history of pancreatitis.
• Baseline labs are standard of care before initiation.
• Dose titration should follow a structured schedule to minimize side effects, typically starting at 0.25 mg for four weeks before escalation.
• Ongoing follow-up matters. Muscle loss is a documented concern with rapid weight loss on GLP-1 agents (Bikou et al., 2023, Nutrients), and protein intake and resistance training are part of responsible clinical management.

The FormBlends position: injection tutorials on social media are not inherently harmful, but they become harmful when they are paired with a DM-to-start sales funnel and no visible prescriber involvement.